400-921-8278
| Catalog_no | ADMC0529 |
| Product_name | SKLB610 |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 1660.00/5000.00/6120.00 |
| Specificity | TargetTargeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR at rate of 97%, 65% and 55%, respectively, at concentration of 10 μM in biochemical kinase assays. |
| Dilution | |
| Purification | >98% |
| Concentration | 靶点：FGFR;IC50：No data |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | SKLB 610; SKLB-610 |
| Observed_band | 415.37 |
| Notes | SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR at rate of 97%, 65% and 55%, respectively, at concentration of 10 μM in biochemical kinase assays. |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
